Enjoy complimentary customisation on priority with our Enterprise License!
About Atherectomy and Thrombectomy Devices
Atherectomy devices are used to remove atherosclerotic plaques to clear blocked blood vessels. Atherosclerotic plaques are deposits of fats, calcium, or other substances inside the blood vessels. It is an endovascular procedure for the treatment of PAD and CAD. PVD refers to damaged or blocked peripheral blood vessels that supply blood to the arms, legs, and organs other than brain and heart. PAD, which is PVD of the arteries, is known to increase the risk of stroke and heart attack by up to six times. CAD is a condition of narrowing of arteries that supply blood to heart muscles. Stents, balloon catheters, atherectomy devices are used in endovascular procedures to treat PVD. Thrombectomy devices are used to surgically remove thrombi (clot) from the blood vessels during the treatment of DVT. DVT is the blood clot formed in deep veins in the body, mainly in legs. The risk of developing these vascular diseases increases with age. Diabetes, high blood pressure, obesity, and smoking are other risk factors for these diseases.
Technavio's analysts forecast the global atherectomy and thrombectomy market to grow at a CAGR of 6.25% over the period 2014-2019.
Covered in this Report
The report includes the present scenario and the growth prospects of the global atherectomy and thrombectomy devices market for the period 2015-2019. The market can be segmented into two divisions: atherectomy devices and thrombectomy devices.
Technavio's report, Global Atherectomy and Thrombectomy Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global atherectomy and thrombectomy devices market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• Boston Scientific Group
• Cardiovascular Systems
• Medtronic
• Spectranetics
Other Prominent Vendors
• Argon Medical Devices
• C.R. Bard
• Cod Man Neuro (DePuy Orthopaedics)
• Cook Medical
• Edwards Lifesciences
• IDEV Technologies (subsidiary of Abbott Vascular)
• Lake Region Medical
• NexGen Medical Systems
• Reverse Medical
• St. Jude Medical
• Teleflex Medical
• Volcano (acquired by Philips)
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
03.2.1 Atherectomy Products
03.2.2 Thrombectomy Products
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Global Atherectomy and Thrombectomy Devices Market
06.1 Market Overview
06.1.1 Market Size and Forecast
07. Global Atherectomy and Thrombectomy Market Segmentation by Product Type
07.1 Atherectomy Devices
07.2 Thrombectomy Devices
07.3 Five Forces Analysis
08. Global Atherectomy Devices Market
08.1 Market Overview
08.1.1 Market Size and Forecast
08.2 Market Segmentation by Procedure Type
09. Global Thrombectomy Devices Market
09.1 Market Overview
09.1.1 Market Size and Forecast
09.2 Market Segmentation by Product Type
09.3 Market Segmentation by Procedure Type
10. Reimbursement Scenario of Atherectomy and Thrombectomy Devices
10.1 Reimbursement Scenario in Americas
10.2 Reimbursement Scenario in EMEA
10.3 Reimbursement Scenario in APAC
11. Geographical Segmentation
11.1 Atherectomy and Thrombectomy Devices Market in the Americas
11.1.1 Market Size and Forecast
11.2 Atherectomy and Thrombectomy Devices Market in EMEA
11.2.1 Market Size and Forecast
11.3 Atherectomy and Thrombectomy Devices Market in APAC
11.3.1 Market Size and Forecast
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Trends and their Impact
19. Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Market Share Analysis 2014
19.3 Other Prominent Vendors
20. Key Vendor Analysis
20.1 Boston Scientific
20.1.1 Key Facts
20.1.2 Business Overview
20.1.3 Business Segmentation
20.1.4 Business Strategy
20.1.5 Business Segmentation by Revenue
20.1.6 Business Segmentation by Revenue 2012 and 2013
20.1.7 Geographical Segmentation by Revenue
20.1.8 Key Developments
20.1.9 SWOT Analysis
20.2 Cardiovascular Systems
20.2.1 Key Facts
20.2.2 Business Overview
20.2.3 Product Segmentation Based on Therapy Areas
20.2.4 Business Strategy
20.2.5 Recent Developments
20.2.6 SWOT Analysis
20.3 Medtronic
20.3.1 Key Facts
20.3.2 Business Overview
20.3.3 Business Segmentation
20.3.4 Revenue by Business Segmentation
20.3.5 Revenue Comparison by Business Segmentation 2012 and 2013
20.3.6 Revenue by Geographical Segmentation
20.3.7 Business Strategy
20.3.8 Key Developments
20.3.9 SWOT Analysis
20.4 Spectranetics
20.4.1 Key Facts
20.4.2 Business Overview
20.4.3 Business Segmentation 2014
20.4.4 Business Segmentation by Revenue 2013 and 2014
20.4.5 Geographical Segmentation by Revenue 2014
20.4.6 Business Strategy
20.4.7 Recent Developments
20.4.8 SWOT Analysis
21. Other Reports in this Series
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.